Загрузка...
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
BACKGROUND: Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-related genes...
Сохранить в:
| Опубликовано в: : | Mol Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584997/ https://ncbi.nlm.nih.gov/pubmed/31221082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-019-0098-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|